Stay updated on XmAb®20717 in Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Major update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.
    Difference
    12%
    Check dated 2025-10-05T17:20:51.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T10:15:11.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.
    Difference
    0.7%
    Check dated 2025-09-14T00:15:40.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.7%
    Check dated 2025-09-06T21:04:09.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    16%
    Check dated 2025-08-30T15:31:39.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T12:21:52.000Z thumbnail image

Stay in the know with updates to XmAb®20717 in Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.